Products
μCaler Total Solution for AML

μCaler Total Solution for AML

μCaler AML MRD comprehensive solution is based on liquid-phase hybridization target enrichment technology and specifically designed for adult Acute Myeloid Leukemia (AML) MRD research. This comprehensive solution selects MRD targets that cover approximately 90% of AML cases, allowing for the analysis of various mutations, including base substitutions, insertions/deletions, and gene fusions. By combining UMI and the μCaler hybrid capture system, it achieves ultra-high detection sensitivity and can complete the entire experimental process within same day. μCaler AML Panel v1.0 is designed for detecting common mutations in adult acute myeloid leukemia. The panel covers approximately 42.5 Kb region of the genome, targeting 32 genes. It enables enrichment of various types of mutation information, including base substitutions, insertions/deletions, and gene fusions, making it suitable for MRD monitoring.
Request Quote

Download Demo Data

如果您无法识别验证码,请点图片更换

Nanodigmbio will contact you within 1 day.

If there are any problems, please contact us by 400 8717 699 / support@njnad.com